2013
DOI: 10.1002/jbm.a.34649
|View full text |Cite
|
Sign up to set email alerts
|

Orthopedic bioactive implants: Hydrogel enrichment of macroporous titanium for the delivery of mesenchymal stem cells and strontium

Abstract: Insufficient implant stability is an important determinant in the failure of cementless prostheses. To improve osseointegration, we aim at generating a bioactive implant combining a macroporous titanium (TT) with a biocompatible hydrogel to encapsulate osteo-inductive factors and osteoprogenitor cells. Amidation and cross-linking degree of an amidated carboxymethylcellulose hydrogel (CMCA) were characterized by FT-IR spectrometry and mechanical testing. Bone marrow mesenchymal stem cells (BMSCs) from osteoarth… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
17
0

Year Published

2014
2014
2020
2020

Publication Types

Select...
8

Relationship

4
4

Authors

Journals

citations
Cited by 28 publications
(18 citation statements)
references
References 50 publications
(62 reference statements)
1
17
0
Order By: Relevance
“…Based on literature data showing that cell populations with equivalent capacity to form bone metastasis also share equal expression of genes related to bone invasion and metastasis [ 13 ], we chose to use a single bone seeking clone [ 14 ], with equivalent bone metastatic potential as compared to other bone seeking clones [ 13 ]. BMSCs were harvested from 3 patients undergoing hip surgery, after informed consent, and were differentiated in osteogenic medium (OM), as described [ 15 ]. BOKL and BMSCs after direct co-culture with BMSCs or MRC-5 were retrieved by enzymatic digestion and separated by FACS sorting.…”
Section: Resultsmentioning
confidence: 99%
“…Based on literature data showing that cell populations with equivalent capacity to form bone metastasis also share equal expression of genes related to bone invasion and metastasis [ 13 ], we chose to use a single bone seeking clone [ 14 ], with equivalent bone metastatic potential as compared to other bone seeking clones [ 13 ]. BMSCs were harvested from 3 patients undergoing hip surgery, after informed consent, and were differentiated in osteogenic medium (OM), as described [ 15 ]. BOKL and BMSCs after direct co-culture with BMSCs or MRC-5 were retrieved by enzymatic digestion and separated by FACS sorting.…”
Section: Resultsmentioning
confidence: 99%
“…Bone marrow-derived human mesenchymal stem cells were obtained harvesting whole bone marrow aspirates from patients undergoing hip surgery and selected by plastic adherence according to an optimized protocol [49]. Cells of passage 7 or lower were cultured in osteogenic medium containing L-ascorbic acid, β-glycerophosphate, cholecalciferol and dexamethasone for at least 2 weeks.…”
Section: Methodsmentioning
confidence: 99%
“…Primary GFP and RFP‐HUVECs were purchased from Angioproteomie (Boston, MA) and used at passage 6. MSCs were harvested from patients undergoing hip surgery after informed consent and isolated as described previously . Briefly, bone marrow aspirate was centrifuged for 10 min at 510 g and washed twice with PBS1X.…”
Section: Methodsmentioning
confidence: 99%